home / stock / wxxwy / wxxwy news

WXXWY News and Press, Wuxi Biologics Cayman Inc ADR From 04/16/19

Stock Information
Company Name: Wuxi Biologics Cayman Inc ADR
Stock Symbol: WXXWY
Market: OTC
Menu
WXXWY WXXWY Quote WXXWY Short WXXWY News WXXWY Articles WXXWY Message Board
Get WXXWY Alerts

News, Short Squeeze, Breakout and More Instantly...
WXXWY - WuXi Biologics Successfully Completed First FDA Routine GMP Inspection

SHANGHAI , April 17, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that its Drug Substance (DS) and Drug P...
WXXWY - WuXi Biologics and I-Mab Biopharma Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs

SHANGHAI , April 16, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and I-Mab Biopharma ("I-Mab"), a biotech company focusi...

WXXWY - WuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership

SHANGHAI and BASEL, Switzerland , April 9, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and NBE-Therapeutics (NBE), a p...

WXXWY - WuXi Biologics Wins 2019 CMO Leadership Awards in All Six Core Categories

SHANGHAI and NEW YORK , April 3, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has received the 2019 C...
WXXWY - WuXi Biologics Receives "Asia's Best CMO of 2018" Award from IMAPAC

SHANGHAI and SINGAPORE , March 26, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (Stock Code: 2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has recei...

WXXWY - WuXi Biologics Receives EMA GMP Certificates

WuXi Biologics to be the first biologics company in China approved by both the U.S. FDA and EMA SHANGHAI and WUXI, China , March 20, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end...

WXXWY - WuXi Biologics Continues to Deliver Record Results

HONG KONG , March 18, 2019 /PRNewswire/ -- WuXi Biologics (Cayman) Inc. ( " WuXi Biologics "  or " the Group ",  stock code: 2269.HK) , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, deve...
WXXWY - WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA

- The second product successfully receiving Breakthrough Therapy Designation that WuXi Biologics has enabled its partner to develop SHANGHAI , Feb. 28, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (Stock code: 2269.HK), a leading global open-access biologics technology...

WXXWY - ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million

SHANGHAI and SEOUL , Feb. 26, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and ABL Bio Corporation ("ABL Bio") (29...

WXXWY - EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo (TM) at WuXi Biologics

WuXi Biologics completed EMA GMP Inspection, the first biologics company in China SHANGHAI , Feb. 19, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics disco...
Previous 10 Next 10